Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
Preprint
Abstract
A proportion of patients surviving acute COVID-19 infection develop post-COVID syndrome (long COVID) encompassing physical and neuropsychiatric symptoms lasting longer than 12 weeks. Here we studied a prospective cohort of individuals with long COVID compared to age/gender matched subjects without long COVID (from the ADAPT study), healthy donors and individuals infected with other non-SARS CoV2 human coronaviruses (the ADAPT-C study). We found highly activated innate immune cells and an absence of subsets of un-activated naïve T and B cells in peripheral blood of long COVID subjects, that did not reconstitute over time. These activated myeloid cells may contribute to the elevated levels of type I (IFN-β) and III interferon (IFN-λ1) that remained persistently high in long COVID subjects at 8 months post-infection. We found positive inter-analyte correlations that consisted of 18 inflammatory cytokines in symptomatic long COVID subjects that was not observed in asymptomatic COVID-19 survivors. A linear classification model was used to exhaustively search through all 20475 combinations of the 29 analytes measured, that had the strongest association with long COVID and found that the best 4 analytes were: IL-6, IFN-γ, MCP-1 (CCL2) and VCAM-1. These four inflammatory biomarkers gave an accuracy of 75.9%, and an F1 score of 0.759, and have also previously been associated with acute severe disease. In contrast, plasma ACE2 levels, while elevated in the serum of people previously infected with SARS-CoV-2 were not further elevated in subjects with long COVID symptoms. This work defines immunological parameters associated with long COVID and suggests future opportunities to prevention and treatment.Keywords
All Related Versions
- Published version: Nature Immunology, 23 (2), 210.
This publication has 62 references indexed in Scilit:
- Human Type 2 Myeloid Dendritic Cells Produce Interferon-λ and Amplify Interferon-α in Response to Hepatitis C Virus InfectionGastroenterology, 2013
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytesJournal of Leukocyte Biology, 2008
- New endogenous CXC chemokine ligands as potential targets in lung emphysemaTrends in Pharmacological Sciences, 2008
- Angiotensin‐converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitorExperimental Physiology, 2008
- Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivorsThorax, 2005
- Cytokine production and modulation: Comparison of patients with chronic fatigue syndrome and normal controlsPsychiatry Research, 2005
- Viruses and interferon: a fight for supremacyNature Reviews Immunology, 2002
- Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2000
- Regulation of the interferon-induced PKR: can viruses cope?Trends in Microbiology, 1995